论文部分内容阅读
目的:对尼莫地平治疗脑出血患者的临床疗效进行观察和探讨。方法:选取2010年10月~2012年5月期间在院治疗的脑出血患者48例作为研究对象,随机将其均分为对照组和治疗组各24例,对照组患者实施常规治疗,治疗组患者则采用常规治疗+尼莫地平的综合治疗方案。结果:经相应治疗后,治疗组患者治疗总有效率高达95.83%,对照组患者则为70.83%,治疗组疗效更为良好,组间差异较为明显,具有统计学意义(P<0.05);在脑血肿和脑水肿体积减少程度方面,治疗组患者改善程度明显优于对照组,组间差异显著,具有统计学意义(P<0.05)。结论:在脑出血患者治疗方案中,尼莫地平具有更为显著的临床疗效,患者恢复更为有利,脑血肿和脑水肿得到更为有效的改善。
Objective: To observe and discuss the clinical effect of nimodipine in patients with intracerebral hemorrhage. Methods: Forty-eight patients with intracerebral hemorrhage treated in our hospital from October 2010 to May 2012 were randomly divided into control group and treatment group (24 cases each). Patients in control group were treated with conventional therapy and treatment group Patients were treated with conventional therapy combined with nimodipine. Results: After treatment, the total effective rate was 95.83% in the treatment group and 70.83% in the control group. The treatment group was more effective and the difference between the two groups was statistically significant (P <0.05) Brain hematoma and brain edema volume reduction, the treatment group patients improved significantly better than the control group, significant difference between the groups, with statistical significance (P <0.05). Conclusion: Nimodipine has more significant clinical curative effect in patients with intracerebral hemorrhage, the recovery is more favorable, and the brain hematoma and cerebral edema are more effectively improved.